RPHRENO
succimer
Image for illustration purposes only.
Presentation:Kit containing 5 vials of lyophilized powder for injectable solution. Sterile product, non-pyrogenic and under nitrogen atmosphere for complexation with the radioisotope metastable technetium-99m (99mTc).
Indications:absolute and relative renal quantification. Assessment of renal cortex. Detection of congenital kidney malformations.
Storage: 2-8°C.
Labeling volume: 4 ml.
Labeling activity: 40 mCi (absolute renal quantification); 100 mCi (relative renal quantification).
Stability post-labeling: 4 hours in room temperature (15 to 30 ºC).
Product expiration date: 12 months.
Number of vials per kit: 5
Registration: 1.7359.0004.001-1
AVAILABLE BY PRESCRIPTION ONLY – RESTRICTED USE TO HOSPITALS.
IF SYMPTOMS PERSIST, A DOCTOR SHOULD BE CONSULTED.
Contraindications, warnings, adverse reactions, drug interactions, precautions and posology: refer to package leaflet.
R2Pharma products are available only by means of medical prescription from a licensed physician.
IF SYMPTOMS PERSIST, A DOCTOR SHOULD BE CONSULTED.
Contraindications, warnings, adverse reactions, drug interactions, precautions and posology: refer to package leaflet.
The content of this page is destined to health professionals.